Explore
Featured
Recent
Articles
Topics
Login
Upload
Featured
Recent
Articles
Topics
Login
Upload
Search Results for ''
published presentations and documents on DocSlides.
rostate cancer PC is the most common cancer and the leading cause of
by callie
279 in Mexico, PC prevalence and the consequent im...
Canadian Cancer Trials Group
by violet
“Who We Are & Where We Are Going”. 2022 Ne...
CANCER SURVIVOR FOCUS GROUP STUDYDeveloping a better understanding of
by angelina
June 2017 1 /MCI; 0 ;/M...
Colorectal cancer (CRC) currently is known to be one of the leading causes of cancer-related deaths
by williams
The earliest neoplastic lesions in CRC development...
Breast Cancer Risk Prediction Using Neural Networks
by natalia-silvester
John Sum. Institute of Technology Management Nati...
Group 8 Alessandra Simari
by titechas
. Stanley . Dervil. . Marley . Ince. Simon . Sach...
Geriatric screening in older adults with cancer using electronical patient-reported outcome measures (PROMs) - a feasible approach in a resource limited setting
by archer465
03.02.2022. Geriatric screening in older adults wi...
SWAG Cancer Alliance Draft Programme Governance
by evelyn
September 2020 . Contents. Background and Context...
A STUDY TO ASSESS THE EFFECTIVENESS OF GUIDED INTERNATIONAL CANCER
by jordyn
A STUDY TO ASSESS THE EFFECTIVENESS OF GUIDED AMON...
A Community Engaged Approach: The Terminate Lung Cancer (TLC) Study
by SunshineFlower
Roberto Cardarelli, DO, MPH, FAAFP. Professor of F...
Where’s the good news in cancer research?
by deborah
Pan Pantziarka. 1. July 28 1993 – April 25 2011....
Cancer Trials 30 years in the making
by dorothy
Professor John . Simes. Director, NHMRC Clinical T...
Māori cancer equity my
by elyana
20 . yr. journey . . Oritetanga. . mo. . te. ...
Pilot Testing a Colorectal Cancer Screening Intervention in American Samoa
by ashley
Background:. Colorectal cancer is the third most c...
Expression of the POTE gene family in human ovarian cancer
by bethany
1
Cancer Lesson 2.4 How are cell activities controlled in a normal cell and disrupted in cancer?
by gristlydell
Do Now. All the cells in our body have the same DN...
Ovarian Cancer * Globally 7
by southan
th. most incident and lethal cancer. New cases: 2...
WNT5A and Breast Cancer Group 1:
by calandra-battersby
Matthew Beatty, Brynn Cullander, Melissa Frank, ...
The challenges for young men with Testicular Cancer
by aaron
Dr Hilary Williams. SpR in Medical Oncology. Impa...
Tobacco/Lung Cancer Working Group
by alexa-scheidler
Participating Institutions. : . Case Western Rese...
Independent Cancer Task force
by calandra-battersby
. Independent . taskforce . charged with. . de...
"Creating a Prostate Cancer Center of Excellence"
by kittie-lecroy
Paul . Sieber. MD FACS. Lancaster Urology. ADT C...
1 Research on cancer
by marina-yarberry
risk. . among. firefighters. Niels Mørup. Dani...
Audit of patients diagnosed with colorectal cancer within t
by giovanna-bartolotta
Clare Westwood. Colorectal Nurse Consultant. Coun...
Prostate Cancer
by debby-jeon
...
Breast cancer screening
by lindy-dunigan
Diana Sarfati. Director, Cancer Control and Scree...
0.0 0.2 0.4 0.6 0.8 1.0 Probability
by emma
1000. 2000. 3000. 4000. 5000. Time to CNS metastas...
Tower Health Medical Group 420 S Fifth Avenue NBuilding Grou
by helene
Ofce HoursMonday to Friday, 8 a.m. to 5 p.m. ...
AbstractAim To determine if activelytreated cancerpatients developi
by emily
6311 Correspondence to:Christian Focan, MD, Ph.D.,...
An overview of the IARC Monographs
by davis
programme's . evaluations of risk. factors for chi...
Implementation Guide
by ceila
1Medicaid State Plan EligibilityIndividuals Needin...
Efx00660069cacy of oxaliplatin with Tijiao and recombinant human endos
by harmony
3886Int J Clin Exp Med 20181143880-3886Langer B St...
ENGAGE AND SUCCEED WITH WAHO
by lam
MEMBERSHIP TYPESRegular 100 annually Licensed onco...
Local and systemic therapies:
by trish-goza
several MODERATE survival gains. MODERATE impro...
Adult Immunization Overview
by karlyn-bohler
Dr. Erica W. Swegler, M.D.. 4/26/17. . One ...
Local and systemic therapies:
by giovanna-bartolotta
several MODERATE survival gains. MODERATE impro...
Heredity Tidbit
by lindy-dunigan
Participants: Facilitator:. Virginia . Carson ...
How to describe a graph
by olivia-moreira
Otherwise called. CUSS. 5. In context. You must w...
Risky Business: Understanding Risk and the Application of N
by jane-oiler
Patti Ragan PhD, MPH, PA-C. Brenda Quincy PhD, MP...
Incidence of
by alida-meadow
hospitalisations. in both groups. Incidence of d...
Load More...